Aldafermin (NGM282)

Aldafermin · NGM Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aldafermin (NGM282), covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) [Phase 2]